![](/img/cover-not-exists.png)
Alirocumab for hyperlipidemia: physiology of PCSK9 inhibition, pharmacodynamics and Phase I and II clinical trial results of a PCSK9 monoclonal antibody
Roth, Eli M, Diller, PhilipVolume:
10
Language:
english
Journal:
Future Cardiology
DOI:
10.2217/fca.13.107
Date:
March, 2014
File:
PDF, 3.97 MB
english, 2014